Visszatérés

Szolgáltatásink az alábbi országokban elérhetőek

Corporate

Európa:

Zászló Albánia Albánia Zászló Bosznia Herzegovina Bosznia Herzegovina Zászló Bulgária Bulgária Zászló Horvátország Horvátország Zászló Ciprus Ciprus Zászló Montenegró Montenegró Zászló Cseh Köztársaság Cseh Köztársaság Zászló Dánia Dánia Zászló Észtország Észtország Zászló Spanyolország Spanyolország Zászló Koszovó Koszovó Zászló Litvánia Litvánia Zászló Lettország Lettország Zászló Luxemburg Luxemburg Zászló Macedónia Macedónia Zászló Németország Németország Zászló Lengyelország  Lengyelország  Zászló Portugália Portugália Zászló Románia Románia Zászló Szerbia Szerbia Zászló Szlovákia Szlovákia Zászló Szlovénia Szlovénia Zászló Svájc Svájc Zászló Svédország Svédország Zászló Törökország Törökország Zászló Magyarország Magyarország Zászló Egyesült Királyság Egyesült Királyság Zászló Olaszország Olaszország

Ázsia:

Zászló UAE UAE Zászló Hong-Kong Hong-Kong Zászló Kuvait Kuvait Zászló Libanon Libanon

Afrika:

Zászló Dél-Afrika Dél-Afrika
Visszahívást kérek

Szeretne többet megtudni szolgáltasainkról?

Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére

    "Adatait semmilyen körülmények között nem tesszük harmadik fél számára hozzáférhetővé.

    Obraz

    Életmentő
    transzplantációk listája

    A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.

    Obraz
    Lp. Őssejt forrás Forrás típusa Diagnózis Érintett szakterület Kezelés éve Terápia Ország Páciens életkora
    1201 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Australia 71
    1202 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 76
    1203 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Canada 66
    1204 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 74
    1205 Apheresis Allogeneic Morbus Hodgkin Hematology 2025 Standard Therapy Germany 21
    1206 Apheresis Allogeneic Myelodysplastic Disorders Hematology 2025 Standard Therapy France 66
    1207 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy USA 65
    1208 Apheresis Allogeneic T Lymphoblastic Lymphoma Hematology 2025 Standard Therapy Portugal 25
    1209 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 29
    1210 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 37
    1211 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 49
    1212 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 32
    1213 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    1214 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
    1215 Apheresis Allogeneic Hodking lymphoma Hematology 2025 Standard Therapy Serbia 32
    1216 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 66
    1217 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1218 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    1219 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 68
    1220 Apheresis Allogeneic OMDS/ Myeloproliferative Neoplasie Hematology 2025 Standard Therapy Switzerland 46
    1221 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 3
    1222 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 75
    1223 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 58
    1224 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Greece 63
    1225 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
    1226 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
    1227 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Spain 49
    1228 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 30
    1229 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    1230 Apheresis Allogeneic Chronic Lymphocyte Leukemia Hematology 2025 Standard Therapy Canada 55
    1231 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
    1232 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 16
    1233 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 73
    1234 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 47
    1235 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
    1236 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 67
    1237 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
    1238 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
    1239 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Germany 57
    1240 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy RUSSIAN FEDERATION 22
    1241 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 33
    1242 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 41
    1243 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Greece 54
    1244 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 46
    1245 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Argentina 26
    1246 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    1247 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 59
    1248 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 34
    1249 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Norway 53
    1250 Apheresis Allogeneic Other Immune System Hematology 2025 Standard Therapy USA 19
    1251 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
    1252 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
    1253 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    1254 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 64
    1255 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 33
    1256 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Italy 63
    1257 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 33
    1258 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 61
    1259 Apheresis Allogeneic Acute lymphocytic leukemia Hematology 2025 Standard Therapy Germany 51
    1260 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 64
    1261 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 54
    1262 Apheresis Autologous Testicular tumor Hematology 2025 Standard Therapy Germany 42
    1263 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    1264 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 49
    1265 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 73
    1266 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62
    1267 Apheresis Autologous Lymphoma Hodgkin Hematology 2025 Standard Therapy Portugal 39
    1268 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 60
    1269 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
    1270 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
    1271 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
    1272 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
    1273 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
    1274 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 43
    1275 Apheresis Allogeneic Myeofibrosis Hematology 2025 Standard Therapy Poland 37
    1276 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 22
    1277 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 66
    1278 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 57
    1279 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
    1280 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 78
    1281 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 65
    1282 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
    1283 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Portugal 41
    1284 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
    1285 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 22
    1286 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
    1287 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 65
    1288 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1289 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Sweden 73
    1290 Apheresis Allogeneic NK LGL Leukemia Hematology 2025 Standard Therapy USA 42
    1291 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 29
    1292 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1293 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1294 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Czechia 64
    1295 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
    1296 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Brazil 57
    1297 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 21
    1298 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Lithuania 54
    1299 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 55
    1300 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 63